Bicara Therapeutics
BCAX
#7214
Rank
โ‚ฌ0.51 B
Marketcap
7,69ย โ‚ฌ
Share price
-7.46%
Change (1 day)
-50.88%
Change (1 year)

EPS for Bicara Therapeutics (BCAX)

EPS in 2026 (TTM): -2,67ย โ‚ฌ

According to Bicara Therapeutics's latest financial reports the company's current EPS (TTM) is -2,83ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,31ย โ‚ฌ an increase over its 2024 EPS that were of -2,33ย โ‚ฌ.

EPS history for Bicara Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,67ย โ‚ฌ15.84%
2025-2,31ย โ‚ฌ-1.21%
2024-2,33ย โ‚ฌ